secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001636422-24-000072
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q1 revenue $74.7M, Adj EBITDA $3.4M; beats guidance mid-point
-----------------------------------------------------------------------------

- Q1 total revenue $74.7M (up 1% YoY), net loss $20.6M (improved 38% from $33.2M loss).
- Adjusted EBITDA $3.4M above Q1 guidance range of $2M-$4M.
- Reiterates FY2024 revenue guidance $304M-$312M and Adj EBITDA $24M-$26M.
- Q2 2024 guidance: revenue $73.5M-$76.5M, Adj EBITDA $5M-$7M.
- New platform branded Health Catalyst Ignite; expansion with Saudi German Health announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000072/0001636422-24-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000072/hcat-20240509.htm
  HTML page:      https://secwatch.observer/filing/0001636422-24-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer